DMF
Dimethyl fumarate (DMF) is an organic compound with the formula (CH₃O₂C)₂C=CH₂. It is the methyl ester of fumaric acid. DMF is used in the treatment of multiple sclerosis (MS) and psoriasis. It is known for its immunomodulatory and anti-inflammatory properties.
Medical Uses[edit]
Multiple Sclerosis[edit]
Dimethyl fumarate is approved for the treatment of relapsing-remitting multiple sclerosis (RRMS). It is believed to work by activating the Nrf2 pathway, which helps protect against oxidative stress and inflammation. Clinical trials have shown that DMF can reduce the frequency of relapses and slow the progression of disability in patients with RRMS.
Psoriasis[edit]
DMF is also used in the treatment of psoriasis, a chronic autoimmune skin disease. It helps to reduce the symptoms of psoriasis by modulating the immune system and reducing inflammation.
Mechanism of Action[edit]
The exact mechanism of action of DMF is not fully understood. However, it is known to activate the Nrf2 pathway, which leads to the expression of antioxidant proteins that protect against oxidative damage triggered by injury and inflammation. DMF also has immunomodulatory effects, which help in reducing the activity of the immune system that attacks the body's own tissues in autoimmune diseases.
Side Effects[edit]
Common side effects of DMF include flushing, gastrointestinal issues such as diarrhea, nausea, and abdominal pain. More serious side effects can include lymphopenia (a reduction in white blood cells) and progressive multifocal leukoencephalopathy (PML), a rare but serious brain infection.
Chemistry[edit]
Dimethyl fumarate is a methyl ester of fumaric acid. It is a white crystalline powder that is soluble in organic solvents. The chemical structure of DMF includes two ester groups attached to a central carbon-carbon double bond.
History[edit]
DMF was first synthesized in the early 20th century. It was initially used as a fungicide and later found to have therapeutic effects in the treatment of psoriasis. In 2013, DMF was approved by the U.S. Food and Drug Administration (FDA) for the treatment of relapsing forms of multiple sclerosis.
Related Pages[edit]
Categories[edit]
| Demyelinating diseases of the central nervous system | ||||||||
|---|---|---|---|---|---|---|---|---|
|
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa
Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
